SCHEMBL20097526

SCHEMBL20097526

CC(=O)c1ccc(N)cc1N1CCOCC1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRKDC P78527 1/20 0.55
MAPT P10636 5/20 0.54
SMN1; SMN2 Q16637 2/20 0.54
GAA P10253 1/20 0.54
ALDH1A1 P00352 5/20 0.54
ALOX15 P16050 2/20 0.46
KDM4E B2RXH2 2/20 0.44
MEN1 O00255 1/20 0.44
THRB P10828 1/20 0.44
GFER P55789 1/20 0.44
YWHAG P61981 1/20 0.44
KMT2A Q03164 1/20 0.44
HSD17B10 Q99714 1/20 0.44
NPC1 O15118 1/20 0.44
HTT P42858 2/20 0.43
LGMN Q99538 1/20 0.43
ATM Q13315 1/20 0.42
PKM P14618 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
HPGD P15428 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL78016 0.88 MAPT (0.58) PRKDCMAPTSMN1; SMN2GAAALDH1A1
SCHEMBL23059699 0.86 MAPT (0.56) PRKDCMAPTSMN1; SMN2GAAALDH1A1
SCHEMBL18669179 0.86 MAPT (0.55) MAPTSMN1; SMN2GAAALDH1A1ALOX15
SCHEMBL21549442 0.84 SMN1; SMN2 (0.50) PRKDCMAPTSMN1; SMN2GAAALDH1A1
SCHEMBL17113124 0.84 GAA (0.51) PRKDCMAPTSMN1; SMN2GAAALDH1A1
SCHEMBL1237577 0.82 ALDH1A1 (0.61) PRKDCMAPTSMN1; SMN2GAAALDH1A1
SCHEMBL4100817 0.81 GAA (0.53) MAPTSMN1; SMN2GAAALDH1A1KDM4E
SCHEMBL24227047 0.81 KDM4E (0.43) MAPTALOX15KDM4EMEN1THRB
SCHEMBL18412927 0.79 ALDH1A1 (0.55) PRKDCMAPTSMN1; SMN2ALDH1A1ALOX15
SCHEMBL20097525 0.79 PRKDC (0.68) PRKDCMAPTSMN1; SMN2ALDH1A1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9957281-B2 Benzodiazepine derivatives as RSV inhibitors ENANTA PHARMACEUTICALS, INC. (US) 2018-05-01 US disclosed